Compare DexCom, Inc. (DXCM) vs Iron Mountain Inc (IRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Iron Mountain Inc — how do they compare? DexCom, Inc. trades at $77.98 (market cap $28.06B), while Iron Mountain Inc trades at $122.72 (market cap $36.75B). The key difference: Iron Mountain Inc is the larger of the two by market cap, and Iron Mountain Inc pays a 2.8% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | IRM | |
|---|---|---|
Market Cap | $28.06B | $36.75B |
Sector | Health | Real Estate |
52-Week High | $89.53 | $133.06 |
52-Week Low | $54.84 | $78.86 |
Enterprise Value | $27.03B | $55.88B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Iron Mountain (IRM) trades at $123.18, up 0.42% on the day, with a bullish trend from recent earnings beats and data center growth. The stock shows strong technical momentum but faces high valuation multiples (P/E 134.26) and elevated debt levels. Recent news highlights data center expansion and a $1.5 billion debt offering, while analyst consensus leans bullish with a $138.67 price target.
Outlook: IRM benefits from recurring revenue and AI-driven data center demand, but high debt and margin pressures pose risks. The stock offers growth potential if execution continues, yet investors must monitor debt sustainability and competitive shifts in information management services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
